Business

Merck wins Chinese obesity drug in nearly $2 billion deal




Merck will win an exclusive global license to Chinese drugmaker Hansoh’s HS-10535, an investigational oral drug targeting the GLP-1 receptor. Read more

News7f

News 7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button